[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Automated External Defibrillator Market Research Report 2022-2032

January 2023 | 215 pages | ID: GC2FE7FA2021EN
Fatpos Global

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Automated External Defibrillator Market to surpass 3,218.3 million by 2032 from USD 1,375.3 million in 2021 at a CAGR of 8.9 % throughout the forecast period 2022-32.

According to a recently published report by Fatpos Global on “Automated External Defibrillator Market” delivers a detailed overview of the market in terms of market segmentation by material type, by thickness, by application, by transparency, by end-use industry, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis, and Porter’s five force model.

This report also provides the existing competitive scenario of some of the key players of the global Automated External Defibrillator Market which includes company profiling of
  • Asahi Kasei Corporation
  • Stryker Corporation
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Philips Healthcare
  • LivaNova PLC
  • Medtronic plc
  • Cardiac Science Corporation
  • Nihon Kohden Corporation
  • St. Jude Medical, Inc.
  • Other Prominent Players
Source Fatpos Global

COVID-19 Impact on Automated External Defibrillator Market

We are making continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreaks across industries to help you prepare for the future.

The COVID-19 outbreak has spawned widespread economic distress and uncertainty, with many industries, markets, and businesses undergoing tremendous stress. However, together, the global community can tide over these challenging times, and at Fatpos Global, we aim to provide precise market intelligence through extensive and intensive research into the impact of this pandemic on various businesses.

Through continuous efforts, we are striving to help your business sustain and grow during the COVID-19 pandemic. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreaks across industries to help you prepare for the future.

Market segment by Region, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The Automated External Defibrillator Market report also contains an analysis on:

Automated External Defibrillator Market Segments
  • By Product
    • Implantable defibrillators
    • External defibrillators
  • By End-User
    • Hospitals, clinics, and cardiac centers
    • Public-access markets
    • Alternate care facilities
    • Home care settings
    • Others
Source Fatpos Global

The Automated External Defibrillator Market report provides answers to the following key questions:
  • What are the key outcomes of the five forces analysis of the global?
  • Which are Trending factors influencing the market shares of the top regions across the globe? What is the impact of Covid19 on the current industry?
  • What are the market opportunities and threats faced by Automated External Defibrillator Market?
1. EXECUTIVE SUMMARY

2. AUTOMATED EXTERNAL DEFIBRILLATOR MARKET

2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3. RESEARCH METHODOLOGY

3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4. AVERAGE PRICING ANALYSIS

5. MACRO-ECONOMIC INDICATORS

6. MARKET DYNAMICS

6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7. CORRELATION & REGRESSION ANALYSIS

7.1. Correlation Matrix
7.2. Regression Matrix

8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE

9. RISK ANALYSIS

9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10. AUTOMATED EXTERNAL DEFIBRILLATOR MARKET ANALYSIS

10.1. Porters Five Forces
  10.1.1. Threat of New Entrants
  10.1.2. Bargaining Power of Suppliers
  10.1.3. Threat of Substitutes
  10.1.4. Rivalry
10.2. PEST Analysis
  10.2.1. Political
  10.2.2. Economic
  10.2.3. Social
  10.2.4. Technological

11. AUTOMATED EXTERNAL DEFIBRILLATOR MARKET

11.1. Market Size & forecast, 2020A-2030F
  11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

12. AUTOMATED EXTERNAL DEFIBRILLATOR MARKET: MARKET SEGMENTATION

12.1. By Regions
  12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By network type: Market Share (2020-2030F)
  12.2.1. Hardware , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.2. Software , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.3. Services , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End user: Market Share (2020-2030F)
  12.3.1. Manufacturing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.2. Healthcare, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.3. Energy and Utilities, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.4. IT & Telecom, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.5. Automotive and Transportation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.6. Supply Chain and Logistics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.7. Government and Public Safety, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.8. Agriculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.9. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
  Asahi Kasei Corporation
  Stryker Corporation
  Biotronik SE & Co. KG
  Boston Scientific Corporation
  Philips Healthcare
  LivaNova PLC
  Medtronic plc
  Cardiac Science Corporation
  Nihon Kohden Corporation
  St. Jude Medical, Inc.
  Other Prominent Players
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.


More Publications